Pulmonary Function Testing Systems Market Research Report and Outlook by 2028

The global market for pulmonary function testing systems is projected to grow significantly, reaching an estimated US$ 401.83 million by 2028, up from US$ 274.10 million in 2022. This market is anticipated to experience a compound annual growth rate (CAGR) of 6.6% from 2022 to 2028.

The increasing prevalence of lung diseases and occupational lung conditions is a key factor driving the expansion of the pulmonary function testing systems market. However, challenges such as the potential for cross-contamination and a shortage of qualified professionals are hindering market progress.

The pulmonary function testing systems market is divided into several regions: North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In 2021, North America dominated the market, with the United States holding the largest share within this region. The growth in this market is attributed to a rise in lung cancer cases and ongoing technological innovations by companies in the area.

Increasing Incidence of Occupational Lung Diseases

Occupational lung diseases significantly influence the demand for pulmonary function testing systems. According to a 2023 report from The Johns Hopkins University, prolonged exposure to specific workplace irritants can lead to chronic lung conditions that severely affect patients' health. Certain jobs expose workers to higher risks of lung diseases due to their work environment. For instance, individuals employed in automotive garages or textile manufacturing may encounter harmful chemicals, dust, and fibers that can result in long-term respiratory issues if not properly diagnosed and treated. Asbestosis, a serious condition caused by inhaling asbestos fibers, is particularly prevalent among workers in construction, manufacturing, and chemical processing industries. The American Lung Association estimates that around 1.3 million workers in these sectors are at risk of asbestos exposure.

Pulmonary function testing is essential for diagnosing occupational lung diseases among employees. The American College of Occupational and Environmental Medicine's 2020 report highlights the importance of spirometry in occupational health, which is crucial for the prevention of work-related lung diseases at primary, secondary, and tertiary levels. The primary goal of workplace spirometry is to identify employees who may need further assessment for lung-related disorders. Spirometry tests are commonly conducted in small clinical settings, within small industries, and across various medical departments in larger organizations. To emphasize the importance of spirometry in workplace respiratory health programs, the American College of Occupational and Environmental Medicine (ACOEM) has established three position statements that enhance occupational health practices.

The pulmonary function testing systems market is categorized by type into cart-based PFT systems and stationary PFT systems. In 2022, the cart-based segment captured the largest market share and is expected to exhibit the highest CAGR during the forecast period. The rising incidence of lung diseases is a significant factor driving the growth of the portable PFT system segment. Additionally, advancements in technology and the increasing availability of innovative portable PFT systems are propelling this market segment forward. The market is also segmented by test type, including spirometry, lung volume measurement, gas exchange testing, maximal voluntary ventilation, oxygen titration tests, and others. The spirometry segment was the largest in 2022, while the lung volume segment is projected to grow at the highest CAGR in the coming years. Furthermore, the market is divided by components into hardware, software, and services, with hardware holding the largest share in 2022. The software segment is expected to see the highest growth rate during the forecast period. In terms of application, the market is segmented into chronic obstructive pulmonary disease (COPD), asthma, chronic shortness of breath, restrictive lung diseases, and others, with COPD being the leading segment in 2022 and anticipated to grow at the highest CAGR. Lastly, the market is segmented by end user into hospitals, specialty clinics, and diagnostic centers, with hospitals holding the largest market share in 2022, while specialty clinics are expected to experience the highest growth rate in the forecast period.

Key organizations such as the World Health Organization (WHO), Dubai Health Authority, National Lung Health Education Program, Centers for Disease Control and Prevention, European Respiratory Society, Organization for Economic Cooperation and Development, and Globocan have been instrumental in providing primary and secondary data for the analysis of the pulmonary function testing systems market.